Preeclampsia is a serious hypertensive disorder that affects roughly 2 per cent to 8 per cent of pregnant women worldwide. Now, the US Food and Drug Administration has approved a blood test that can help predict Preeclampsia earlier in pregnant women. The new test works by detecting sFlt1 and PIGF-- two proteins in the blood that predict poor outcomes from …
Controversy Kicks Up Over A Drug Meant To Prevent Premature Birth Enlarge this image toggle caption Jill Lehmann Photography/Getty Images Jill Lehmann Photography/Getty Images An independent panel of advisers to the Food and Drug Administration recommended last week that a medication to prevent preterm birth be taken off the market because, the advisers decided, the preponderance of evidence suggests it …
